Statistical flag only — not an accusation of fraud
⚠️ This provider averages 1.1K services per working day — physically unusual for an individual practitioner
Based on 2.7M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $24.3M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 1.1K services per working day raises questions about billing patterns.
Medicare payments to this provider grew 668% from 2014 to 2023.
This provider has been statistically flagged with a risk score of 66/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 222% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $31.46 | $11.79 | 2.67x | $19.67 | $506.1K | 42.9K | 27 |
| 2015 | $43.56 | $15.52 | 2.81x | $28.04 | $1.6M | 104.9K | 37 |
| 2016 | $21.09 | $7.89 | 2.67x | $13.20 | $1.6M | 203.7K | 42 |
| 2017 | $20.61 | $7.53 | 2.74x | $13.08 | $2.0M | 259.1K | 51 |
| 2018 | $25.33 | $10.31 | 2.46x | $15.02 | $3.4M | 325.7K | 62 |
| 2019 | $19.92 | $7.73 | 2.58x | $12.19 | $3.2M | 415.4K | 57 |
| 2020 | $24.86 | $9.14 | 2.72x | $15.72 | $3.2M | 346.8K | 58 |
| 2021 | $17.63 | $6.28 | 2.81x | $11.35 | $2.4M | 375.1K | 55 |
| 2022 | $20.32 | $7.76 | 2.62x | $12.56 | $2.6M | 337.1K | 54 |
| 2023 | $42.88 | $12.15 | 3.53x | $30.73 | $3.9M | 320.1K | 58 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 120.2K | $4.9M | $41.12 | 2.20x |
| J2505 | Injection, pegfilgrastim, 6 mg | 651 | $2.1M | $3.2K | 1.97x |
| J0897 | Injection, denosumab, 1 mg | 133.4K | $2.0M | $15.29 | 1.95x |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 1.5K | $1.5M | $1.0K | 2.68x |
| J9299 | Injection, nivolumab, 1 mg | 53.8K | $1.2M | $21.76 | 2.33x |
| J9035 | Injection, bevacizumab, 10 mg | 15.0K | $900.0K | $59.95 | 2.08x |
| J9310 | Injection, rituximab, 100 mg | 1.2K | $757.8K | $642.24 | 2.07x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 6.6K | $650.4K | $98.53 | 2.92x |
| J9041 | Injection, bortezomib, 0.1 mg | 21.5K | $617.5K | $28.73 | 3.15x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 71.7K | $611.5K | $8.53 | 3.77x |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 59.1K | $529.0K | $8.95 | 2.12x |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 3.0K | $482.9K | $162.93 | 4.14x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 7.5K | $396.5K | $53.10 | 1.84x |
| J9022 | Injection, atezolizumab, 10 mg | 6.0K | $385.1K | $63.93 | 2.68x |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 10.2K | $378.7K | $37.06 | 3.67x |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | 5.1K | $356.5K | $69.50 | 2.50x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 4.0K | $331.8K | $82.53 | 1.77x |
| J2796 | Injection, romiplostim, 10 micrograms | 5.2K | $310.0K | $59.59 | 2.03x |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 9.1K | $301.1K | $33.02 | 4.63x |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 333.8K | $284.9K | $0.85 | 2.57x |
This provider submits charges 2.79 times higher than what Medicare actually pays.
A markup ratio of 2.79x means for every $100 Medicare pays, this provider initially charges $279. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in KS for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Pavan Reddy, M.D. | Wichita, KS | $52.9M | ⚠️ Flagged |
| Bassam Mattar, MD | Wichita, KS | $50.2M | ⚠️ Flagged |
| Dennis Moore, MD | Wichita, KS | $44.1M | ⚠️ Flagged |
| Shaker Dakhil, MD | Wichita, KS | $41.0M | ⚠️ Flagged |
| Jeremy Deutsch, MD | Wichita, KS | $39.7M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data